Company Description

Core Biotherapeutics, formerly NewBio, is the first company harnessing network science, single-cell omics, and generative AI to create drugs that restore healthy gene regulation by reprogramming transcription factor networks to produce safe, deep and consistent therapeutic effects where other drugs cannot.